COMMUNIQUÉS West-GlobeNewswire

-
Persephone Biosciences Announces Full Enrollment in AMBROSIA Food as Medicine Study
28/01/2025 -
Precision Optics Launches Revolutionary Unity Imaging Platform
28/01/2025 -
Sharps Technology, Inc. Announces Pricing of Upsized $20.0 Million Underwritten Public Offering
28/01/2025 -
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions
28/01/2025 -
Better Choice Company Signs Non-Binding Term Sheet to Sell Halo Asia for $6.5 Million in Cash at Closing and a 5-Year Royalty Valued at a Minimum of $1.65 Million
28/01/2025 -
BioAge Labs Announces Company Updates on APJ, NLRP3, and Platform Programs
28/01/2025 -
New Survey from Aeroflow Sleep Reveals Disparities Around Women’s Sleep Health
28/01/2025 -
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBump
28/01/2025 -
Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
28/01/2025 -
Eterna Therapeutics Announces Expansion of Scientific Advisory Board
28/01/2025 -
Silexion Therapeutics Reports Strong Tumor Growth Reduction from Systemic Administration of SIL-204 in Preclinical Pancreatic Cancer Models
28/01/2025 -
Polarean and SimonMed Announce Collaboration to Advance Lung Imaging Innovation
28/01/2025 -
Evaxion granted 180-day compliance extension by Nasdaq as it restores equity above minimum requirement
28/01/2025 -
FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY
28/01/2025 -
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
28/01/2025 -
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
28/01/2025 -
Lighthouse Autism Center Announces New Location in South Sioux City, Nebraska, creating 35 Jobs and Serving 25 Families
28/01/2025 -
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
28/01/2025 -
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
28/01/2025
Pages